Cita APA

Gaibar, M., Novillo, A., Romero-Lorca, A., Malón, D., Antón, B., Moreno, A., . . . Novillo Villajos, A. (2022). FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

Citación estilo Chicago

Gaibar, María, Apolonia Novillo, Alicia Romero-Lorca, Diego Malón, Beatriz Antón, Amalia Moreno, Ana Fernández-Santander, y Apolonia Novillo Villajos. FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer. 2022.

Cita MLA

Gaibar, María, et al. FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer. 2022.